Mga Androgen at Anabolic Steroid

Mahahalagang Punto

• Ang androgens (halimbawa testosterone) ay pumapalit sa kulang na endogenous hormone sa hypogonadism at delayed puberty pathways.
• Ang anabolic steroids (halimbawa oxandrolone) ay ginagamit sa piling catabolic/wasting conditions para itaguyod ang tissue rebuilding at pagdagdag ng timbang.
• Available ang testosterone sa oral, injectable, transdermal, buccal, at implantable forms; formulation-specific ang dosing.
• Kabilang sa pangunahing risks ang cardiovascular/hepatic adverse effects, virilization effects, at misuse para sa bodybuilding/performance enhancement.
• Sa prepubertal clients, maaaring pabilisin ng androgen exposure ang bone maturation at maagang maisara ang epiphyseal growth plates.
• May high-priority liver at lipid-risk warnings ang oxandrolone at isa itong DEA Schedule III controlled substance.
• Sa masculinizing transgender regimens, karaniwang pinananatili ang testosterone targets sa male physiologic range at nangangailangan ng structured follow-up monitoring.

Drug Class Overview

Ang androgens ay natural o synthetic testosterone-pathway drugs na kumakapit sa androgen receptors at sumusuporta sa development/maintenance ng male sexual characteristics, anabolic metabolism, at erythropoiesis. Ginagamit ang mga ito sa clinically confirmed androgen-deficiency states at piling oncology contexts.

Ang anabolic steroids ay testosterone analogs na dinisenyo para pataasin ang protein synthesis at suportahan ang tissue rebuilding sa severe catabolic illness, trauma, long-term corticosteroid exposure, o postoperative recovery pathways.

Common Agents and Typical Dosing

Class	Drug	Typical Adult Dose Range
Androgen	Testosterone (IM o transdermal pathways)	50-400 mg IM bawat 2-4 na linggo, o transdermal 4 mg/araw na ina-adjust ayon sa serum levels
Androgen	Fluoxymesterone	5-20 mg PO araw-araw para sa hypogonadism/delayed puberty pathways
Androgen	Methyltestosterone	10-50 mg PO araw-araw para sa hypogonadism/delayed puberty pathways
Anabolic steroid	Oxandrolone	2.5-20 mg/araw PO sa 2-4 hinating doses

Adverse Effects and Contraindications

Androgen adverse-effect patterns:

• Gynecomastia, acne, edema, mood o libido changes, prolonged erections/priapism risk
• Mga senyales ng liver dysfunction (kabilang ang cholestatic jaundice)
• Panganib ng hypercalcemia sa immobilized clients
• Virilization effects sa female clients (paglalim ng boses, hirsutism, pagpapalaki ng clitoris, menstrual irregularity)

Anabolic steroid adverse-effect patterns:

• Electrolyte retention/imbalance, edema, paglala ng lipids, hypertension
• Hepatic injury (kabilang ang bihirang necrosis), insomnia, anxiety/depression/aggression
• Male gonadal suppression/testicular atrophy at libido changes
• Female virilization at posibleng fetal masculinization kapag na-expose sa pagbubuntis

Major contraindication trends:

• Pregnancy/lactation pathways
• Kilalang prostate o male breast cancer
• Severe cardiac, hepatic, o renal disease
• Hypercalcemia o nephrosis contexts (agent-specific)

Oxandrolone Black Box Context

Maaaring magdulot ang oxandrolone ng seryosong hepatic injury at adverse serum-lipid shifts na nagpapataas ng coronary-risk burden. Sa mga bata, ang pinabilis na bone maturation ay maaaring magpababa ng final adult height.

Nursing Assessment and Monitoring

• Kumpirmahin ang indikasyon at i-screen ang misuse/nonmedical goals bago simulan ang therapy.
• Suriin ang cardiovascular, hepatic, renal, oncologic, at pregnancy/lactation history.
• Kumuha ng baseline at follow-up labs ayon sa order: CBC, liver/renal function, serum chemistries, at lipid profile.
• I-track ang blood pressure, timbang, taas, at mood/behavior changes.
• Sa clients na may diabetes na gumagamit ng androgen therapy, i-monitor ang glucose-lowering effects at i-coordinate ang posibleng antihyperglycemic dose adjustments.
• Sa prepubertal therapy pathways, i-coordinate ang long-bone radiographs humigit-kumulang bawat 6 na buwan para ma-monitor ang epiphyseal maturation.
• I-monitor ang paglala ng BPH/prostate symptoms at urinary-obstruction cues sa older male clients.

Patient Education

• Inumin nang eksakto ayon sa reseta; huwag mag-self-adjust o biglang itigil ang therapy.
• I-report agad ang chest pain, dyspnea, matinding mood change, persistent erection, jaundice, o edema.
• Iwasan ang paninigarilyo at alcohol habang nasa therapy dahil sa additive cardiovascular/hepatic risk.
• Panatilihin ang follow-up appointments para sa laboratory at growth monitoring.
• Huwag gumamit ng androgens/anabolic steroids para sa bodybuilding o athletic performance enhancement.

Related Concepts

• oncologic-hormonal-therapy - Mga antiandrogen pathway sa advanced prostate-cancer treatment.
• gonadotropin-releasing-hormone-gnrh-analogs - Mga pinagsamang androgen-deprivation pathways sa metastatic prostate cancer.
• masculinizing-hormonal-therapy - Regimen-level monitoring targets at transgender-focused counseling priorities.
• controlled-substances-and-drug-schedules - Schedule III controlled-substance handling at diversion prevention.
• benign-prostatic-hyperplasia - Maaaring magpalala ang testosterone pathways ng lower-urinary-tract symptoms sa susceptible clients.
• prostate-cancer - Baseline at interval prostate-risk evaluation sa androgen-exposed male clients.

Self-Check

1. Aling baseline assessments ang pinakamahalaga bago simulan ang testosterone replacement sa older client?
2. Bakit kailangan ang long-bone radiographs habang nasa androgen therapy ang prepubertal clients?
3. Aling oxandrolone adverse-effect clusters ang nangangailangan ng agarang escalation?